Dr. Rajveer Purohit is the Director of Reconstructive Urology and Associate Professor of Urology at The Mount Sinai Hospital. He is co-director of the 1 year Society of Genitourinary Reconstructive Surgeons (GURS) certified reconstructive urology fellowship for advanced training of the next generation of reconstructive surgeons.
Dr. Purohit has performed over 1000 complex reconstructive surgical procedures including urethroplasty for urethral strictures, repair of fistula, and gender affirming surgery including vaginoplasty, metoidioplasty and phalloplasty. He offers a variety of techniques for these gender affirmation surgeries.
Dr. Purohit earned his medical degree (MD) from Columbia University before completing his surgical internship and urology residency at the University of California in San Francisco. While there he trained with one of the pioneers of male urethral reconstruction and then completed a fellowship in pelvic reconstruction.
He has published widely, lectured internationally on urethral reconstruction and gender affirmation surgery and has co-authored a textbook on voiding dysfunction and is currently working on a second textbook on techniques in gender affirmation surgery. In addition he has served as a reviewer for multiple urological journals.
He has been chosen by his colleagues for inclusion in Castle Connolly’s Best Doctors and listed in New York Magazine’s Best Doctors in New York City. Dr. Purohit is a Diplomate of the American Board of Urology and a member of the Society of Genitourinary Reconstructive Surgeons (GURS), World Professional Association for Transgender Health (WPATH), and the American Urological Association.
Dr. Purohit is fluent in Hindi, Urdu and Spanish.
Follow Dr. Purohit on Twitter for information on conferences he attends, interviews he gives, or to ask questions/leave comments.
Certification
American Board of Urology
Clinical Focus
• Gay, Lesbian, Bisexual, Transgender Services
• Gender Affirmation Surgery
• Gender Confirmation Surgery
• Penile Inversion Vaginoplasty
• Peritoneal Flap Vaginoplasty
• Minimal Depth Vaginoplasty
• Metoidioplasty with urethral lengthening
• Metoidioplasty without urethral lengthening
• Simple Release Metoidioplasty
• Penile prosthesis after phalloplasty
• Abdominal phalloplasty
• Urethroplasty after phalloplasty
• Fistula repair after phalloplasty
• Varicocele
• Hypospadias complications
• Incontinence Surgery
• Penile Prosthesis Insertion
• Penis Malformation
• Peyronie's Disease
• Urethral stricture surgery
• Artificial urinary sphincter (AUS) placement
• Urethroplasty
• Urinary Fistula
Education
MD, Columbia University School of Public Health
Internship, General Surgery
University of California (San Francisco)
Residency, Urology
University of California (San Francisco)
Fellowship, Pelvic Reconstruction and Voiding Dysfunction
Urocenter of New York
Language
English, Hindi, Urdu
Certifications
American Board of Urology
Clinical Focus
- Gay, Lesbian, Bisexual, Transgender Services
- Gender Affirmation Surgery
- Gender Confirmation Surgery
- Incontinence Surgery
- Kidney Cancer
- Penile Prosthesis Insertion
- Peyronie's Disease
- Reconstructive Surgery
- Testicular Cancer
- Ureteral Stone
- Urethral Disorders
- Urethral Suspension-Sling Procedure
- Urethral stricture surgery
- Urethroplasty
- Urinary Fistula
- Vasectomy
Education
MD, Columbia University School of Public Health
Internship, General Surgery, University of California (San Francisco)
Residency, Urology, University of California (San Francisco)
Fellowship, Pelvic Reconstruction and Voiding Dysfunction, Urocenter of New York
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Purohit did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.